Comparison of Pruritus Incidence After Intrathecal Morphine 0.1 vs 0.2 mg in Cesarean Section
Recruiting
Phase 4
Interventional Study
Pruritus Caused by Drug
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 45
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 69 (estimated)
- Sponsor
- Khon Kaen University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study compares the incidence of pruritus (itching) requiring treatment between two doses of intrathecal morphine (0.1 mg vs 0.2 mg) when used for spinal anesthesia during cesarean section. The study aims to determine if the lower dose (0.1 mg) can reduce pruritus incidence while maintaining adequate pain relief.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: • Pregnant women aged 18-45 years
* Full-term pregnancy
* Scheduled for non-emergency cesarean section
* ASA physical status I-III
* Non-complicated pregnancy
Exclusion Criteria:
* Contraindication to spinal anesthesia or study drugs
* Refusal to participate in the study
* BMI…
Contacts